 
 
 
Date: 26 August 2025    
         
          Ref. No.: TCPCL/SEC/2025-26/00038 
 
To, 
The General Manager, 
 
 
 
The Manager, 
Corporate relationship department, 
Listing department, 
BSE Limited  
 
 
 
 
 
National Stock Exchange of India Limited 
Phiroze Jeejeebhoy Towers,  
 
 
Exchange Plaza, C-1, Block-G, 
Dalal Street, Fort,  
 
 
 
 
Bandra-Kurla Complex, Bandra(E), 
Mumbai-400 001  
 
 
 
 
Mumbai-400 051 
Scrip Code: 543321 
 
 
 
 
Scrip Symbol: TATVA 
 
Subject: Submission of Business Responsibility and Sustainability Report of the 
Company for the Financial Year (“FY”) 2024-25 under Regulation 34(2)(f) of 
the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 
(“SEBI Listing Regulations”) 
 
Dear Sir/Madam,  
 
Pursuant to Regulation 34(2)(f) of the SEBI Listing Regulations, we are submitting herewith 
the Business Responsibility and Sustainability Report (“BRSR”) for FY 2024-25 which 
forms part of the Annual Report FY 2024-25.  
 
The BRSR is also available on the website of the Company at www.tatvachintan.com. 
 
Kindly take the above information on record. 
 
Thanking you, 
 
Yours faithfully, 
For Tatva Chintan Pharma Chem Limited 
 
 
 
___________ 
Ishwar Nayi 
Company Secretary and Compliance Officer 
M. No.: A37444 
 
Encl.: As above 
ISHWAR 
RAMANBHAI 
NAYI
Digitally signed by 
ISHWAR RAMANBHAI 
NAYI 
Date: 2025.08.26 
16:31:32 +05'30'
Annexure - H to the Board’s Report 
Business Responsibility and Sustainability Report
Section A: General Disclosures
I.	
Details of the listed entity:
1.
Corporate Identity Number (CIN) of the Listed Entity
L24232GJ1996PLC029894
2.
Name of the Listed Entity
Tatva Chintan Pharma Chem Limited
3.
Year of Incorporation
1996
4.
Registered Office Address
Plot No. 502/17, GIDC Estate, Ankleshwar, Dist. Bharuch,  
Gujarat - 393002, India
5.
Corporate Address
Plot No. 353, Makarpura GIDC, Vadodara, Gujarat – 390010, India
6.
E-mail
cs@tatvachintan.com
7.
Telephone
+91-7574848533/34
8.
Website
www.tatvachintan.com
9.
Financial year for which reporting is being done
01 April 2024 to 31 March 2025
10.
Name of the Stock Exchange(s) where shares are listed
1. BSE Limited (BSE); and
2. National Stock Exchange of India Limited (NSE)
11.
Paid-up Capital
` 233.92 Million
12.
Name and contact details (telephone, email address) of the 
person who may be contacted in case of any queries on the 
BRSR report
Mr. Chintan N. Shah
Chairman and Managing Director 
Telephone number: +91 75748 48533/34 
Email ID: chintan@tatvachintan.com
13.
Reporting boundary - Are the disclosures under this report 
made on a standalone basis (i.e. only for the entity) or on 
a consolidated basis (i.e. for the entity and all the entities 
which form a part of its consolidated financial statements, 
taken together).
Standalone Basis
14.
Name of assurance provider
Not Applicable
15.
Type of assurance obtained
Not Applicable
II.	
Products / Services:
16.	 Details of business activities (accounting for 90% of the turnover):
Description of main activity
Description of business activity
% of turnover of the entity
Specialty Chemicals
Manufacturing of specialty chemical with diverse portfolio of Structure 
Directing Agents, Phase Transfer Catalysts, Electrolyte Salts and 
Solutions and Pharmaceutical and Agrochemical Intermediates and 
Other Specialty Chemicals
99.23%
17.	 Products / Services sold by the entity (accounting for 90% of the entity’s Turnover):
Sr. 
No.
Product / Service
NIC Code
% of total turnover 
contributed
1
Structure Directing Agents (SDA)
20119
33.66%
2
Phase Transfer Catalysts (PTC)
20119
30.09%
3
Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC)
20119
34.31%
4
Electrolyte Salts and Solutions (ESS)
20119
1.17%
III.	 Operations:
18.	 Number of locations where plants and / or operations / offices of the entity are situated:
Locations
Number of plants
Number of offices
Total
National
2
2
4
International
0
0
0
STATUTORY 
REPORTS
01
ANNUAL REPORT 2024-25
19.	 Markets served by the entity:
a.	
Number of locations:
Locations
Number
National (no. of states)
18
International (no. of countries)
34
b.	
What is the contribution of exports as a percentage of the total turnover of the entity?
	
59.82%
c.	
A brief on types of customers:
	
We have a wide customer base spread across major geography and across diverse sectors including:
-	 Agro chemicals
-	 Active pharmaceuticals ingredients
-	 Zeolites manufactures
-	 Chemicals / Specialty chemicals
-	 Personal care and hygiene
-	 Super capacitors and energy storage devices
-	 Resins
-	 Mining and metals industry
	
The Company serves customers directly as well as through agents.
IV.	 Employees
20.	 Details as at the end of Financial Year:
a.	
Employees and workers (including differently abled)
Sr. 
No.
Particulars
Total (A)
Male
Female
No. (B)
% (B / A)
No. (C)
% (C / A)
EMPLOYEES
1.
Permanent (D)
349
329
94.27 %
20
5.73%
2.
Other than Permanent (E)
0
0
0%
0
0%
3.
Total employees (D + E)
349
329
94.27%
20
5.73%
WORKERS
4.
Permanent (F)
330
330
100%
0
0%
5.
Other than Permanent (G)
260
259
99.62%
1
0.38%
6.
Total workers (F + G)
590
589
99.83%
1
0.17%
b.	
Differently abled Employees and workers:
Sr. 
No.
Particulars
Total (A)
Male
Female
No. (B)
% (B / A)
No. (C)
% (C / A)
DIFFERENTLY ABLED EMPLOYEES
1.
Permanent (D)
1
1
100%
0
0%
2.
Other than Permanent (E)
0
0
0%
0
0%
3.
Total differently abled employees (D + E)
1
1
100%
0
0%
DIFFERENTLY ABLED WORKERS
4.
Permanent (F)
0
0
0%
0
0%
5.
Other than Permanent (G)
0
0
0%
0
0%
6.
Total differently abled workers (F + G)
0
0
0%
0
0%
02
TATVA CHINTAN PHARMA CHEM LIMITED
21.	 Participation / Inclusion / Representation of women:
Total
No. and percentage of Females
(A)
No. (B)
% (B / A)
Board of Directors (BOD)*
6
1
16.67%
Key Management Personnel (KMP)*
5
0
0%
 
*Mr. Chintan N. Shah, Chairman and Managing Director, Mr. Ajaykumar M. Patel, Whole time Director and Mr. Shekhar R. Somani, Whole time Director, 
are part of both BOD and KMP.
22.	 Turnover rate for permanent employees and workers
FY 2024-25
(Turnover rate in %)
FY 2023-24
(Turnover rate in %)
FY 2022-23
(Turnover rate in %)
Male
Female
Total
Male
Female
Total
Male
Female
Total
Permanent Employees
30.81%
35.71%
30.06%
24.08%
21.28%
23.96%
26.85%
46.15%
27.60%
Permanent Workers
21.76%
0%
21.76%
15.68%
0%
15.68%
10.70%
100%
11.07%
V.	
Holding, Subsidiary and Associate Companies (Including Joint Ventures)
23.	 (a) Names of holding / subsidiary / associate companies / joint ventures:
Sr.
No
Name of the holding / 
subsidiary / associate 
companies / joint ventures (A)
Indicate whether holding
/ subsidiary / associate /
joint venture
% of shares 
held by listed 
entity
Does the entity indicated at column A, 
participate in the business responsibility 
initiatives of the listed entity? (Yes/No)
1
Tatva Chintan USA Inc.
Wholly Owned Subsidiary of 
the Company
100%
No
2
Tatva Chintan Europe B.V.
Wholly Owned Subsidiary of 
the Company
100%
No
VI.	 CSR Details
24.	 i.	
Whether CSR is applicable as per section 135 of Companies Act, 2013: Yes
	
ii.	
Turnover (in `): 3,664.15 Million (FY 2024-25)
	
iii.	
Net worth (in `): 7,213.12 Million (FY 2024-25)
VII.	 Transparency and Disclosures Compliances
25.	 Complaints / Grievances on any of the principles (Principles 1 to 9) under the National Guidelines on Responsible Business Conduct:
Stakeholder 
group from whom 
complaint is 
received
Grievance redressal 
mechanism in place
FY 2024-25
FY 2023-24
If Yes, then provide 
web-link for 
grievance redress 
policy
Number of 
complaints 
filed during 
the year
Number of 
complaints pending 
resolution at close
of the year
Remarks
Number of 
complaints 
filed during 
the year
Number of 
complaints pending 
resolution at close of 
the year
Remarks
Communities
Yes. Please refer Note 
A1 below
0
0
NA
0
0
NA
Investors (other 
than shareholders)
Yes. Please refer Note 
A2 below
0
0
NA
0
0
NA
Shareholders
Yes. Please refer Note 
A3 below
1
0
NA
2
0
NA
Employees and 
workers
Yes. Please refer Note 
A4 below
0
0
NA
0
0
NA
Customers
Yes. Please refer Note 
A5 below
10 
0
NA
2
0
NA
Value Chain 
Partners
Yes. Please refer Note 
A6 below
0
0
NA
0
0
NA
Other (please 
specify)
Not Applicable
STATUTORY 
REPORTS
03
ANNUAL REPORT 2024-25
	
Notes:
	
A1: At all our manufacturing locations, we ensure that there is regular engagement on a pro-active basis with the local communities 
and their representatives. As such no complaint has been received during the year and there is no long standing grievances at any of 
our locations.
	
A2: The link to Investor Grievance Redressal is as follow: 
	
https://www.tatvachintan.com/investors-contacts.aspx
	
A3: Yes. Shareholder can register their grievances at https://scores.sebi.gov.in/ 
	
A4: The link to Grievance Redressal Policy for Employees is as follows: 
	
https://www.tatvachintan.com/corporate-governance.aspx
	
A5: Customer complaints and feedback are received by the marketing department, and addressed / attended to by them and the 
team of respective manufacturing facility. Complaints are tracked till its closure.
	
In the detailed monthly review meeting, the details of all the complaints and the resolution status is shared, and corrective actions 
are discussed to eliminate such issues in future.
	
A6: The link to Grievance Redressal Policy for Supply Chain Partner is as follows: 
	
https://www.tatvachintan.com/corporate-governance.aspx
26.	 Overview of the entity’s material responsible business conduct issue:
	
Please indicate material responsible business conduct and sustainability issues pertaining to environmental and social matters that 
present a risk or an opportunity to your business, rationale for identifying the same, approach to adapt or mitigate the risk along-with 
its financial implications, as per the following format:
Sr. 
No .
Material issue 
identified
Indicate 
whether risk 
or opportunity 
(R/O)
Rationale for identifying 
the risk / opportunity
In case of risk, approach to adapt or mitigate
Financial implications of 
the risk or opportunity 
(Indicate positive or 
negative implications
1.
Health and 
Safety
Risk
Health and Safety can 
directly impact people and 
community and disrupt the 
operations.
Health and Safety Management Plan, continuous 
Training, Process Safety and Risk Management 
etc.
Policies (internal) and rigorous trainings for 
employees and workers against health and 
safety hazards. In addition, safety campaigns, 
Mock Drills, Safety Week, Safety Committee 
Meeting are being conducted / celebrated and 
communication of all significant hazards across 
sites, factories and offices etc.
The Company minimize safety and health risks 
by encouraging employees or workers to report 
unsafe conditions or near miss events and 
redressal thereafter.
Negative
2.
Business 
ethics
Risk
Failure 
to 
adhere 
to 
business ethics may impact 
the brand and trust of 
stakeholders.
We adhere to the highest standards when it 
comes to personal and collective integrity, 
reflected by compliance with the standards 
stipulated by the government and other 
regulatory agencies. Over the years, we have 
further strengthened our commitment to 
gender respect, zero tolerance for sexual 
harassment, 
zero 
tolerance 
on 
ethical
Negative
04
TATVA CHINTAN PHARMA CHEM LIMITED
Sr. 
No .
Material issue 
identified
Indicate 
whether risk 
or opportunity 
(R/O)
Rationale for identifying 
the risk / opportunity
In case of risk, approach to adapt or mitigate
Financial implications of 
the risk or opportunity 
(Indicate positive or 
negative implications
transgressions, commitment to recruit without 
prejudice and appraise without partialness, 
respect for the dignity of people and 
environment integrity and respect for the laws 
of the lands of our presence. 
The Company has also formulated and 
implemented a Code of Business Conduct and 
Ethics for all its Board members and senior 
management personnel, in compliance with 
corporate governance requirements as per 
the SEBI Listing Regulations. Apart from this, 
Tatva Code of Conduct is also applicable to all 
employees which serves as a guide to each 
employee on the standards of values, ethics, 
and business principles.
3.
Employee 
development
Opportunity
This may have the ability 
to attract, develop, and 
retain a skilled workforce, 
thereby 
boosting 
innovation, 
productivity, 
and 
competitiveness. 
It 
enhances 
employee 
competence, skills, and 
knowledge, 
which 
are 
crucial for organizational 
growth. Effective employee 
management also improves 
engagement, morale, and 
job satisfaction, resulting 
in lower attrition rates 
and increased employee 
loyalty.
NA
Positive
4.
Community 
relations and 
engagement
Opportunity
Community development 
activities help the Company 
to create a positive impact 
on society by undertaking 
meaningful interventions 
to bring significant benefits 
to large sections of society.
The 
CSR 
efforts 
also 
help 
foster 
a 
more 
productive and positive 
work 
environment 
for 
employees.
NA
Positive
5.
Corporate 
governance
Opportunity
Good corporate governance 
creates transparent rules 
and 
controls, 
guides 
leadership, 
and 
aligns 
the interests of various 
stakeholders.
NA
Positive
STATUTORY 
REPORTS
05
ANNUAL REPORT 2024-25
Sr. 
No .
Material issue 
identified
Indicate 
whether risk 
or opportunity 
(R/O)
Rationale for identifying 
the risk / opportunity
In case of risk, approach to adapt or mitigate
Financial implications of 
the risk or opportunity 
(Indicate positive or 
negative implications
6.
Waste 
management
Risk
Waste management has 
become a global issue 
impacting the environment 
and health of the people. 
Industries 
are 
one 
of 
the large generators of 
hazardous waste and are 
directed by the Pollution 
Control 
Board 
(PCB) 
for waste management 
practices. Not abiding to 
the practices prescribed 
the PCBs may lead to legal 
penalties and impact the 
brand image.
The Company has defined processes for 
managing waste at each of its sites / locations. 
We follow the basic principle of segregation of 
the waste at source and adopt the 3R concept of 
“reduce, reuse and recycle”.
Negative
7.
Water 
stewardship
Opportunity
This 
may 
help 
in 
sustainable water balance, 
improve 
availability 
of 
water, 
becoming 
water 
neutral / positive.
Focus on minimising consumptions & efluent 
generation and reuse of treated efluent.
Our Ankleshwar manufacturing unit is Zero 
Liquid Discharge Units since January 2020.
Working on water reduction projects. We have 
taken up multiple water conservation projects 
like recycling, condensate recovery and steam 
recovery.
Positive
8.
Reducing GHG 
emissions
Opportunity
Undertake GHG emissions 
reduction 
initiatives 
through refraining from 
high 
polluting 
fuel, 
increased use of electricity 
from renewable sources 
and 
implement 
energy 
efficient measures.
NA
Positive
9.
Air emissions
Risk
Exceeding the designated 
limits set by the State 
Pollution Control Board 
(SPCB) may result in fines 
and penalties.
Ensure monitoring of all sources of air pollutants in 
Company’s manufacturing locations. Undertake 
measures to reduce SOx, NOx and PM emissions.
Negative
10.
Stakeholder 
engagement
Opportunity
As 
we 
move 
towards 
growing 
into 
a 
more 
sustainable 
business, 
inclusion 
of 
various 
stakeholders in our growth 
journey is very important. 
We take their inputs to 
plan our business strategy. 
We 
are 
continuously 
engaging 
with 
the 
employees, 
investors, 
suppliers, 
Service 
providers, 
customers 
etc. 
through 
employee 
engagement 
initiatives, 
Investor 
meet, 
Vendor 
Meet, etc. on periodical 
basis.
NA
Positive
06
TATVA CHINTAN PHARMA CHEM LIMITED
Sr. 
No .
Material issue 
identified
Indicate 
whether risk 
or opportunity 
(R/O)
Rationale for identifying 
the risk / opportunity
In case of risk, approach to adapt or mitigate
Financial implications of 
the risk or opportunity 
(Indicate positive or 
negative implications
11.
Key material 
procurement 
and 
management
Risk
Failure 
to 
adhere 
to 
ESG practices and EHS 
compliance by suppliers 
could result in disruptions 
to the supply chain.
Increase awareness among raw material 
suppliers to implement ESG practices.
Positive
12.
Risk 
management 
and operation 
compliance 
Risk
Effective risk management 
and regulatory compliance 
are 
critical 
for 
Tatva 
Chintan 
due 
to 
the 
complex 
and 
evolving 
nature of environmental 
regulations in the chemical 
industry. Non-compliance 
could result in severe 
consequences, 
including 
fines, 
legal 
challenges, 
operational 
disruptions, 
and long-term damage to 
stakeholder trust.
The company must implement a robust 
enterprise risk management (ERM) system, 
conduct periodic compliance audits and provide 
targeted training to employees. Leveraging 
digital tools to monitor compliance status 
and regulatory changes can further enhance 
operational integrity and resilience.
Negative
Section B: Management and Process Disclosures
This section is aimed at helping businesses demonstrate the structures, policies and processes put in place towards adopting the NGRBC
Principles and Core Elements.
The National Guidelines on Responsible Business Conduct (NGRBC) released by the Ministry of Corporate Affairs has updated and adopted 
nine areas of Business Responsibility. These are briefly as under:
P1
Businesses should conduct and govern themselves with integrity and in a manner that is ethical, transparent and accountable
P2
Businesses should provide goods and services in a manner that is sustainable and safe
P3
Businesses should respect and promote the well-being of all employees, including those in their value chains
P4
Businesses should respect the interests of and be responsive to all its stakeholders
P5
Businesses should respect and promote human rights
P6
Businesses should respect and make efforts to protect and restore the environment
P7
Businesses, when engaging in influencing public and regulatory policy, should do so in a manner that is responsible and transparent
P8
Businesses should promote inclusive growth and equitable development
P9
Businesses should engage with and provide value to their consumers in a responsible manner
Disclosure questions
P1
P2
P3
P4
P5
P6
P7
P8
P9
Policy and management processes
1
(a) Whether your entity’s policy / policies cover each 
principle and its core elements of the NGRBCs. (Yes/ 
No)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
(b) Has the policy been approved by the Board? (Yes/No)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
(c)
Web Link of the Policies, if available
Policies are available on:  
https://www.tatvachintan.com/corporate-governance.aspx
2
Whether the entity has translated the policy into 
procedures. (Yes/No)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
3
Do the enlisted policies extend to your value chain 
partners? (Yes/No)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
STATUTORY 
REPORTS
07
ANNUAL REPORT 2024-25
Disclosure questions
P1
P2
P3
P4
P5
P6
P7
P8
P9
4
Name of the national and international codes/ 
certifications / labels / standards (e.g. Forest 
Stewardship Council, Fairtrade, Rainforest Alliance, 
Trustee) standards (e.g. SA 8000, OHSAS, ISO, BIS) 
adopted by your entity and mapped to each principle
We have state-of-the-art facilities situated at Dahej and Ankleshwar 
that comply with ISO 9001 (Quality), ISO 14001 (Environment) and 
ISO 45001 (Health & Safety Management) standards. Dahej Plant is 
accredited with ISO 22716 (Good Manufacturing Practices (GMP) and 
Together for Sustainability (TfS) and our all sites are accredited with 
EcoVadis.
5
Specific commitments, goals and targets set by the 
entity with defined timelines, if any
Tatva Chintan Pharma Chem Limited has established a robust 
roadmap for responsible growth through clear Environment, Social 
and Governance goals. 
Environment:
20% reduction in intensity in terms of physical output (per tonne of 
production) based carbon emissions (GHG) by 2030, base year FY 
2023-2024, including through use of renewable energy to source.
Engagement with 30% of top 10 raw material suppliers (value wise) 
and top 10 customers (value wise) by 2030. 
Social: 
Directly / Collaborate with NGOs to promote education, rural 
development projects, promote environmental sustainability, and 
facilitate access to healthcare in the community. 
Average 16 EHS training hours per employee (including non-
permanent employee) per year. 
Governance:
Zero tolerance of corruption and bribery.
6
Performance of the entity against the specific 
commitments, goals and targets along-with reasons in 
case the same are not met:
We have made measurable progress towards our sustainability 
commitments during the reporting period: 
Environment:
The Company has initiated multiple initiatives aligned with its carbon 
intensity reduction target. These include scaling up renewable energy 
procurement and implementing energy-efficient practices across 
operations. Additional renewable energy opportunities are currently 
being evaluated to further reduce dependence on fossil fuels and 
bridge the remaining gap towards achieving the 2030 target.
During the reporting period, the Company engaged with key 
stakeholders by sharing sustainability-related ideas, documentation, 
and participating in relevant training sessions. Engagements were 
carried out with 31 raw material suppliers and 8 customers. 
Social: 
The Company, either Directly / Collaborate with NGOs, has actively 
implemented several CSR initiatives during the reporting period. 
These initiatives focused on promoting education, advancing rural 
development, supporting environmental sustainability and improving 
healthcare access for local communities. Further details are available 
in the ESG section of this report.
The Company has provided an average of 20 EHS training hours 
per employee (including non-permanent employees) during 
the reporting period, thereby surpassing its annual training 
target and reinforcing its commitment to workplace safety and 
environmental stewardship.
Governance:
No instances of corruption or bribery were reported during the 
reporting period. The Company remains firmly committed to the 
highest standards of ethical conduct and corporate integrity.
08
TATVA CHINTAN PHARMA CHEM LIMITED
Governance, Leadership and Oversight
7.	
Statement by director responsible for the business responsibility report, highlighting ESG related challenges, targets and 
achievements (listed entity has flexibility regarding the placement of this disclosure).
	
The Company is committed towards Environmental, Social, and Governance (ESG) principles in its business. These principles help 
protect the environment and improve the quality of life for the communities the Company serves. The Company takes care to 
ensure its products and services are safe and environmentally friendly. The Company has also committed to reducing its carbon 
emissions (Scope 1 and 2) in line with the Science Based Targets initiative (SBTi). The Company has established policies for climate 
change, environment, air pollution, and water management. Socially, the Company is dedicated to fair and responsible practices 
for its employees, workers, and the community. It ensures safe, clean, and healthy working conditions and treats everyone fairly. 
The Company also works to support the local communities where it operates and helps in their inclusive growth. These efforts are 
supported by its CSR Policy and Human Rights Policy.
	
Our governance philosophy is strengthened through Tatva Code of Conduct, Prevention of Insider Trading and various other policies.
8.	
Details of the highest authority responsible for implementation and oversight of the Business Responsibility policy(ies).
	
Mr. Chintan N. Shah, Chairman and Managing Director (DIN: 00183618) under the guidance of the Board of Directors and its 
Committees is responsible for the implementation and oversight of the Business Responsibility policies.
9.	
Does the entity have a specified committee of the Board / Director responsible for decision making on sustainability related issues? 
(Yes/No). If Yes, provide details.
	
Yes, the Company has a Committee for Corporate Social Responsibility and Risk Management. For other policies, the Company has put 
in place an internal framework / Committees to monitor their implementation from time to time.
10.	 Details of Review of NGRBCs by the Company.
Subject for review
Indicate whether review was 
undertaken by Director / Committee of 
the Board / Any other Committee
Frequency (Annually / Half yearly / 
Quarterly / Any other - please specify)
P1 / P2 / P3 / P4 / P5 / P6 / P7 / P8 / P9 P1 / P2 / P3 / P4 / P5 / P6 / P7 / P8 / P9
a
Performance against above policies and 
follow up action
Yes
Annually
b
Compliance with statutory requirements 
of relevance to the principles, and 
rectification of any non-compliances
Yes
Annually
P1
P2
P3
P4
P5
P6
P7
P8
P9
11.
Has the entity carried out independent 
assessment / evaluation of the working 
of its policies by an external agency? 
(Yes/No). If Yes, provide name of the 
agency.
While the Company has not carried out an independent audit of the policies, the 
policies are periodically reviewed by the Board and its Committees as well as Auditors of 
respective functions like ISO Auditors, Internal Auditors and Secretarial Auditors, etc., In 
addition, Tatva Chintan is certified for ISO 9001, ISO 14001, ISO 22716 and ISO 45001 of 
which assessments are done by external agency. They assess the policies and procedures 
maintained by the organization, as part of the certification process.
12.	 If answer to question (1) above is “No” i.e. not all Principles are covered by a policy, reasons to be stated:
Questions
P1
P2
P3
P4
P5
P6
P7
P8
P9
a
The entity does not consider the Principles material to its business (Yes/No)
NA
b
The entity is not at a stage where it is in a position to formulate and implement the 
policies on specified principles (Yes/No)
NA
c
The entity does not have the financial or / human and technical resources available 
for the task (Yes/No)
NA
d
It is planned to be done in the next financial year (Yes/No)
NA
e
Any other reason (please specigy)
NA
STATUTORY 
REPORTS
09
ANNUAL REPORT 2024-25
Section C: Principle Wise Performance Disclosure
This section is aimed at helping entities demonstrate their performance in integrating the Principles and Core Elements with key processes 
and decisions. The information sought is categorized as “Essential” and “Leadership”. While the essential indicators are expected to be 
disclosed by every entity that is mandated to file this report, the leadership indicators may be voluntarily disclosed by entities which aspire 
to progress to a higher level in their quest to be socially, environmentally and ethically responsible. As the leadership indicators are not 
mandatory, the Company has not provided data / details related to leadership indicators under this report.
PRINCIPLE 1: Businesses should conduct and govern themselves with integrity, and in a manner that is Ethical, Transparent 
and Accountable.
Essential Indicators:
1.	
Percentage coverage by training and awareness programmes on any of the principles during the financial year:
Segment
Total	number of 
training and  
awareness 
programmes held
Topics / principles covered Under the training and its impact
% age of persons in 
respective category 
covered by the 
awareness programme
Board of 
Directors (BoD)
4
During the year, the Board of Directors of the Company (including 
its Committees) has invested time on various matters relating to an 
array of issues pertaining to the business, regulations, economy and 
environmental, social, governance parameters.
100%
Key Managerial 
Personnel 
(KMPs)
4
In addition to above referred topics / principles, familiarization 
of business environment and related risks, Changes in regulatory 
framework, ESG and sustainability practices, code of conduct, 
Prevention of Sexual Harassment at Workplace (POSH) etc.
100%
Employees 
other than BoD 
and KMPs
317
Domain & Technical, Environment, Health & Safety, Human Rights, 
Quality Management, POSH & Organizational Values.
100%
Workers
490
Domain & Technical, Environment, Health & Safety, Human Rights, 
Quality Management, POSH & Organizational Values.
100%
2.	
Details of fines / penalties / punishment / award / compounding fees / settlement amount paid in proceedings (by the entity or by 
directors / KMPs) with regulators / law enforcement agencies / judicial institutions, in the financial year, in the following format
	
(Note: the entity shall make disclosures on the basis of materiality as specified in Regulation 30 of SEBI (Listing Obligations and 
Disclosure Obligations) Regulations, 2015 and as disclosed on the entity’s website):
Monetary
NGRBC 
Principle
Name of the regulatory / 
enforcement agencies / 
judicial institutions
Amount 
(In `)
Brief of the case
Has an appeal  
been preferred? 
(Yes/No)
Penalty / Fine
Principle 6
Gujarat Pollution Control 
Board
450,000
The Company was directed by the 
Gujarat Pollution Control Board to pay 
Environment 
Damage 
Compensation 
for alleged violations of Section 33(A) 
of the Water (Prevention and Control of 
Pollution) Act, 1974.
No
Settlement
NA
NA
NA
NA
NA
Compounding Fee
NA
NA
NA
NA
NA
Non - Monetary
NGRBC 
Principle
Name of the regulatory / 
enforcement agencies / 
judicial institutions
Brief of the case
Has an appeal been preferred? (Yes/No)
Imprisonment
NA
NA
NA
NA
Punishment
NA
NA
NA
NA
10
TATVA CHINTAN PHARMA CHEM LIMITED
3.	
Of the instances disclosed in Question 2 above, details of the Appeal / Revision preferred in cases where monetary or non-monetary 
action has been appealed.
Case Details
Name of the regulatory / enforcement agencies / judicial institutions
Not Applicable
4.	
Does the entity have an anti-corruption or anti-bribery policy? If yes, provide details in brief and if available, provide a web-link to 
the policy.
	
Yes. It is a part of our Code of Conduct. We ensure all our systems are operated ethically. It shows the commitment and zero tolerance 
of the Company and its management for maintaining the highest ethical standards while undertaking open and fair business practices 
and culture, and implementing and enforcing effective systems to detect, counter and prevent bribery and other corrupt business 
practices.
	
Web-link to the policy:
	
https://www.tatvachintan.com/corporate-governance.aspx.
5.	
Number of Directors / KMPs / employees / workers against whom disciplinary action was taken by any law enforcement agency for 
the charges of bribery / corruption.
FY 2024-25
FY 2023-24
Directors
0
0
KMPs
0
0
Employees
0
0
Workers
0
0
6.	
Details of complaints with regard to conflict of interest:
FY 2024-25
FY 2023-24
Number
Remarks
Number
Remarks
Number of complaints received in relation to issues of Conflict of Interest of 
the Directors.
0
NA
0
NA
Number of complaints received in relation to issues of Conflict of Interest of 
the KMPs.
0
NA
0
NA
7.	
Provide details of any corrective action taken or underway on issues related to fines / penalties / action taken by regulators / law 
enforcement agencies / judicial institutions, on cases of corruption and conflicts of interest.
	
Not applicable
8.	
Number of days of accounts payables [(Accounts payable *365)/Cost of goods/service procured] in the following format:
Designation
FY 2024-25
FY 2023-24
Number of days of accounts payables
60
96
9.	
Openness of business - Provide details of concentration of purchases and sales with trading houses, dealers, and related parties 
along-with loans and advances & investments, with related parties, in the following format:
Parameter
Metrics
FY 2024-25
FY 2023-24
Concentration 
of Purchases
a.	
Purchase from trading houses as % of total purchases
21.33%
23.08%
b.	
Number of trading houses where purchases are made from
38
56
c.	
Purchases from top 10 trading houses as % of total purchases 
from trading houses
78.90%
61.00%
Concentration 
of Sales
a.	
Sales to dealers / distributors as % of total sales
1.37%
2.08%
b.	
Number of dealers / distributors to whom sales are made
25
18
c.	
Sales to top 10 dealers / distributors as % of total sales to dealers 
/ distributors
98.91%
98.72%
Share of RPTs 
(as respective 
%) in
a.	
Purchases (purchases with related parties / Total Purchases)
-
-
b.	
Sales (Sales to related parties / Total Sales)
26.36%
23.64%
c.	
Loans and advances (Loans and advances given to related parties 
/ Total loans and advances)
-
-
d.	
Investments (Investments in related parties / Total Investments 
made)
-
-
STATUTORY 
REPORTS
11
ANNUAL REPORT 2024-25
PRINCIPLE 2: Businesses should provide goods and services in a manner that is sustainable and safe.
Essential Indicators:
1.	
Percentage of R&D and capital expenditure (capex) investments in specific technologies to improve the environmental and social 
impacts of product and processes to total R&D and capex investments made by the entity, respectively.
Current Financial 
Year(%)
Previous Financial 
Year (%)
Details of improvements in environmental and social impacts
R & D
-
- While the Company makes significant investments in development of new 
sustainable and green technologies, however, we have not measured the 
impact specifically. 
Capex
7.81%
1.41% Employee health and safety and energy saving.
2.	
a. 	
Does the entity have procedures in place for sustainable sourcing? (Yes/No)
	
	
Yes, the Company has formulated a standard operating procedure to encourage such vendors. The quality assurance team of the 
Company conducts periodic audits of the vendors, especially those who supply large value / volume materials. The core element 
of an audit is to assess whether the vendor’s products and services for operation are ethical, sustainable, and socially conscious, 
and also to encourage them to achieve and improve sustainability standards.
	
b.	
 If yes, what percentage of inputs were sourced sustainably?
	
	
The Company has sourced approximately 62.73% of its raw materials sustainably.
3.	
Describe the processes in place to safely reclaim your products for reusing, recycling and disposing at the end of life, for (a) Plastics 
(including packaging) (b) E-waste (c) Hazardous waste and (d) other waste.
	
(a)	
Plastics (including packaging)
	
	
All our finished goods (FG) are raw materials for our customer, hence we don’t require them to reclaim. 
	
	
Though if any of our products are rejected at the customer’s end or in transit we have a procedure in place to reclaim them and 
reprocess or dispose of it in a safe manner with pollution control Board’s authorised recycler. 
	
	
Damaged material is brought back to the plant, and reprocessed as per SOP or through contracting process or disposed of. For 
exported material, customers are required to safely dispose of the product as per local regulations.
	
(b)	
E-waste
	
	
The e-waste is handed over to certified vendors for safe disposal through the pollution control Board’s authorised recycler.
	
(c)	
Hazardous waste
	
	
Hazardous waste is categorised as per the Rules and is sent for proper disposal at the Pollution Control Board’s authorised 
recycler.
	
(d)	
Other waste
	
	
Not Applicable
4.	
Whether Extended Producer Responsibility (EPR) is applicable to the entity’s activities (Yes/No). If yes, whether the waste collection 
plan is in line with the Extended Producer Responsibility (EPR) plan submitted to Pollution Control Boards? If not, provide steps 
taken to address the same.
EPR applicable (Yes/No)
Yes
Describe
Yes, the Company is in compliance with the requirements of Extended Producer Responsibility (EPR) 
under the Plastic Waste Management Rules, 2016 (as amended).
12
TATVA CHINTAN PHARMA CHEM LIMITED
PRINCIPLE 3: Businesses should respect and promote the well-being of all employees, including those in their value chains.
Essential Indicators:
1.	
a.	
Details of measures for the well-being of employees: 
Category
% of employees covered by
Total (A)
Health insurance
Accident insurance Maternity benefits Paternity Benefits Day Care facilities
Number 
(B)
% 
(B /(A)
Number 
(C)
% 
(C / A)
Number 
(D)
% 
(D / A)
Number 
(E)
% 
(E /A)
Number 
(F)
% 
(F / A)
Permanent employees
Male
329
329
100%
329
100%
0
0%
0
0%
0
0%
Female
20
20
100%
20
100%
20
100%
0
0%
0
0%
Total
349
349
100%
349
100%
20
5.73%
0
0%
0
0%
Other than Permanent employees
Male
0
0
0%
0
0%
0
0%
0
0%
0
0%
Female
0
0
0%
0
0%
0
0%
0
0%
0
0%
Total
0
0
0%
0
0%
0
0%
0
0%
0
0%
	
b. 	
Details of measures for the well-being of workers:
Category
% of workers covered by
Total (A)
Health insurance
Accident insurance Maternity benefits Paternity Benefits Day Care facilities
Number 
(B)
%  
(B /(A)
Number 
(C)
%  
(C / A)
Number 
(D)
%  
(D / A)
Number 
(E)
%  
(E /A)
Number 
(F)
%  
(F / A)
Permanent workers
Male
330
330
100%
330
100%
0
0%
0
0%
0
0%
Female
0
0
0%
0
0%
0
0%
0
0%
0
0%
Total
330
330
100%
330
100%
0
0%
0
0%
0
0%
Other than Permanent workers
Male
259
259
100%
259
100%
0
0%
0
0%
0
0%
Female
1
1
100%
1
100%
1
100%
0
0%
0
0%
Total
260
260
100%
260
100%
1
0.38%
0
0%
0
0%
	
C. 	
Spending on measures towards well-being of employees and workers (including permanent and other than permanent) in the 
following format –
FY 2024-25
FY 2023-24
Cost incurred on well-being measures as a % of total revenue from operations of 
the company
1.30%
1.70%
2.	
Details of retirement benefits, for the current and previous financial year.
Benefits
FY 2024-25
FY 2023-24
No. of employees 
covered as a % of 
total employees
No. of workers 
covered as a % of 
total workers
Deducted and 
deposited with 
the authority 
(Y/N/N.A.)
No. of employees 
covered as a % of 
total employees
No. of workers 
covered as a % 
of total workers
Deducted and 
deposited with 
the authority 
(Y/N/N.A.)
PF*
100%
100%
Y
100%
100%
Y
Gratuity*
100%
100%
Y
100%
100%
Y
ESI*
100%
100%
Y
100%
100%
Y
Others please 
specify
	
* Wherever and / or as applicable.
3.	
Accessibility of workplaces
	
Are the premises / offices of the entity accessible to differently abled employees and workers as per the requirements of the Rights 
of Persons with Disabilities Act, 2016? If not, whether any steps are being taken by the entity in this regard.
	
Yes, our office and manufacturing unit are accessible to differently abled employees and workers.
STATUTORY 
REPORTS
13
ANNUAL REPORT 2024-25
4.	
Does the entity have an equal opportunity policy as per the Rights of Persons with Disabilities Act, 2016? If so, provide a web-link 
to the policy.
	
Yes, equal opportunity is covered as part of our Code of Conduct.
	
https://www.tatvachintan.com/corporate-governance.aspx.
	
The Company provides equal opportunities to all its employees and to all eligible applicants for employment in the Company. It does 
not unfairly discriminate on any ground including race, caste, religion, colour, ancestry, marital status, gender, sexual orientation, age, 
nationality, ethnic origin, disability or any other category protected by applicable law.
5.	
Return to work and Retention rates of permanent employees and workers that took parental leave.
Gender
Permanent employees
Permanent workers
Return to work rate
Retention rate
Return to work rate
Retention rate
Male
0
0
0
0
Female
0
0
0
0
Total
0
0
0
0
6.	
Is there a mechanism available to receive and redress grievances for the following categories of employees and workers? If yes, 
give details of the mechanism in brief.
Yes/No(If Yes, then give details of the mechanism in brief)
Permanent Workers
Yes, the Company has a structured Grievance Redressal Mechanism procedure, Whistle 
blower Policy, Suggestion Box Scheme and Vigil Mechanism to provide a formal platform 
to employees and workers to report their concerns about resource requirement, unethical 
behaviour, actual or suspected fraud or violation of the Company’s Code of Conduct. The Policy 
provides for adequate safeguards against the victimisation of employees or workers who avail 
of these mechanisms. The Company is committed to create a healthy working environment 
and encourage employees and workers to share their concerns with their department head, 
HR or other member of the senior management. The Company has zero tolerance for sexual 
harassment and believes that all employees and workers of the Company have the right to 
be treated with dignity. The Company has formed Internal Complaint Committees for each 
location that are accessible to all employees and workers. All the polices are the part of the 
induction programme and the Company on regular basis sensitises its employees and workers 
on the same through training, workshop and awareness programmes.
Other than Permanent Workers
Permanent Employees
Other than Permanent Employees
7.	
Membership of employees and workers in association(s) or Unions recognized by listed entity:
Category
FY 2024-25
FY 2023-24
Total 
employees/ 
workers in 
respective 
category (A)
No. of employees / 
workers in respective 
category, who are 
part of association(s) 
or Union (B)
% (B / A)
Total 
employees 
/ workers in 
respective 
category (C)
No. of employees / 
workers in respective 
category, who are 
part of association(s) 
or Union (D)
% (D / C)
Total Permanent Employees
349
0
0%
377
0
0%
Male
329
0
0%
359
0
0%
Female
20
0
0%
18
0
0%
Total Permanent Workers
330
0
0%
312
0
0%
Male
330
0
0%
312
0
0%
Female
0
0
0%
0
0
0%
14
TATVA CHINTAN PHARMA CHEM LIMITED
8.	
Details of training given to employees and workers:
FY 2024-25
FY 2023-24
Total 
(A)
On Health and safety / 
wellness measures
On Skill  
upgradation
Total
(D)
On Health and safety / 
wellness measures
On Skill  
upgradation
No.(B)
%(B/A)
No.(C)
%(C/A)
No.(E)
% (E/D)
No.(F)
%(F/D)
Employees
Male
329
329
100%
329
100%
359
359
100%
359
100%
Female
20
20
100%
20
100%
18
18
100%
18
100%
Total
349
349
100%
349
100%
377
377
100%
377
100%
Workers
Male
330
330
100%
330
100%
312
312
100%
312
100%
Female
0
0
0%
0
0%
0
0
0%
0
0%
Total
330
330
100%
330
100%
312
312
100%
312
100%
9. 	
Details of performance and career development reviews of employees and workers:
Category
FY 2024-25
FY 2023-24
Total (A)
No. (B)
% (B/A)
Total (C)
No. (D)
% (D/C)
Employees
Male
329
329
100%
359
359
100%
Female
20
20
100%
18
18
100%
Total
349
349
100%
377
377
100%
Workers
Male
330
330
100%
312
312
100%
Female
0
0
0%
0
0
0%
Total
330
330
100%
312
312
100%
10.	 Health and safety management system:
	
a.	
Whether an occupational health and safety management system has been implemented by the entity? (Yes/No). If yes, the 
coverage such system?
	
	
Yes, occupational health and safety management system has been implemented as per ISO 45001:2018 and certified.
	
b.	
What are the processes used to identify work-related hazards and assess risks on a routine and non-routine basis by the 
entity?
	
	
To identify routine and non-routine work related hazards, a job specific Hazard Identification and Risk Assessment (“HIRA”) is 
prepared. The Material Safety Data Sheet (“MSDS”) is followed for storage and handling of chemical.
	
	
A HAZOP study is carried out for all the products and Pre-start up safety review (“PSSR”) is carried out before operation. Third 
party safety audit is conducted to identify any kind of hazard at site and internal audit is also done after every six months. 
Organisation is having system to report all the unsafe acts, unsafe conditions, near-miss and incident at site, which are linked 
with a reward and recognition system.
	
c.	
Whether you have processes for workers to report the work related hazards and to remove themselves from such risks. (Y/N)
	
	
Yes, we encourage our employees to report near-miss incidents identified through various platforms which is analysed by senior 
manager in consultation with safety department officials. All sites have specific procedure for reporting of work-related hazard, 
injuries, unsafe condition and unsafe act. Remedial Action is taken for accidents and near miss so that the same is not occurred 
in the future.
	
d.	
Do the employees / workers of the entity have access to non-occupational medical and healthcare services? (Yes/No)
	
	
Yes, the Company is organising half yearly medical check-up for all the employees and workers. Health Awareness camps are 
being organised in the plants on regular basis. All employees and workers are covered under health insurance scheme / ESI 
scheme.
STATUTORY 
REPORTS
15
ANNUAL REPORT 2024-25
11.	 Details of safety related incidents:
Safety Incident / Number
Category
FY 2024-25
FY 2023-24
Lost Time Injury Frequency Rate (LTIFR) (per one million-person 
hours worked)
Employees
0
0
Workers
0
0
Total recordable work-related injuries
Employees
0
0
Workers
0
0
No. of fatalities
Employees
0
0
Workers
0
0
High consequence work-related injury or ill-health (excluding 
fatalities)
Employees
0
0
Workers
0
0
12.	 Describe the measures taken by the entity to ensure a safe and healthy work place.
	
The Company has a thorough system in place to ensure workplace health and safety. PPEs (personal protective equipment) is ensured 
before undertaking any job. Permit to work system along with LOTO (lock out & tag out) is followed to identify and eliminate any 
non- routine work hazard at site. For all the routine activities SOPs are prepared and followed. To manage any emergency, we have 
ambulance and a well-equipped firefighting system with the firefighting team getting training from a third party on a regular basis. 
Mock drill is conducted as per schedule to check for response during any emergency for safe evacuation, rescue and firefighting. All 
the new joining employees, workers and visitors must go through safety induction programme and job related to functional area is 
arranged for all the workers & employees.
	
To ensure this Tatva Chintan has implemented robust safety measures across all its workplaces and facilities over the years to lay 
the foundation to a culture of conducive safe working environment wherein proper safety protocols are adhered to, an accident 
reporting system, safety equipment is given the due importance and orderly work locations are maintained. The Company’s strive to 
achieve the same is validated by the ISO 14001:2015 certification bestowed upon the Company for its health, safety, and environment 
management systems. The Company also regularly conducts mock drills, safety trainings and on-the-job training sessions to create 
awareness of health and safety for its personnel.
13.	 Number of Complaints on the following made by employees and workers:
FY 2024-25 
FY 2023-24 
Filed during 
the year 
Pending resolution 
at the end of year
Remark
Filed during 
the year 
Pending resolution 
at the end of year
Remark
Working conditions
0
0
NA
0
0
NA
Health and Safety
0
0
NA
0
0
NA
14.	 Assessments for the year:
% of your plants and offices that were assessed  
(by entity or statutory authorities or third parties)
Health and safety practices
100%
Working Conditions
100 %
15	
Provide details of any corrective action taken or underway to address safety-related incidents (if any) and on significant risks / 
concerns arising from assessments of health and safety practices and working conditions.
	
All safety-related accidents are being investigated and learnings from investigation reports are shared across organisation for 
deployment of corrective actions to stop recurrence of such incidents. Effectiveness of Corrective actions deployment being checked 
during safety Audits. Significant risks / concerns arising from assessment of Health and Safety Practices are addressed through 
hierarchy of risk controls.
PRINCIPLE 4: Businesses should respect the interests of and be responsive to all its stakeholders.
Essential Indicators:
1.	
Describe the processes for identifying key stakeholder groups of the entity.
	
The Company has identified its internal and external group of stakeholders and below listed stakeholder groups have an immediate 
impact on the operations and working of the Company. This includes Employees, Shareholders, Customers, Communities, Suppliers, 
Service Provider, Business Partners and Vendors.
16
TATVA CHINTAN PHARMA CHEM LIMITED
2.	
List stakeholder groups identified as key for your entity and the frequency of engagement with each stakeholder group.
Stakeholder 
Group
W h e t h e r 
identified as 
Vulnerable & 
Marginalized 
Group (Yes/ 
No)
Channels of communication 
(Email, 
SMS, 
Newspaper, 
Pamphlets, 
Advertisement, 
Community Meetings, Notice 
Board, Website), Other
Frequency 
of 
engagement (Annually 
/ Half yearly/Quarterly 
/ 
others 
– 
please 
specify)
Purpose and scope of engagement 
including key topics and concerns raised 
during such engagement
Employees 
and Workers
No
Meetings, Email, Posters, 
Slogans, Notice Board.
Ongoing
General Feedback, Grievances, to share 
relevant 
and 
useful 
information 
to 
employees, Employee Success, Legal 
Compliance, 
Motivation, 
Operational 
efficiencies, improvement areas, long-term 
strategy plans, training and awareness, 
health, safety and engagement initiatives
Shareholders 
and Investors
No
Email, SMS, Newspaper
advertisement, website
Quarterly / Half yearly / 
Annually / Periodically 
and 
as 
and 
when 
required
Dividends, Annual Financial statements 
and other related information, Corporate 
Governance Practice
Customers
No
Email, meetings, website
Ongoing
Informing them about products of the 
Company, feedback, etc.
Suppliers
No
Emails, meetings
Ongoing
Supply of materials / services.
Community
No
Directly or through CSR 
implementation partner
Ongoing
Education, sustainability, empowerment, 
health, infrastructure, conservation, etc.
Central, State 
and Local 
Government, 
Various 
Statutory and 
Regulatory 
Bodies
No
Email, Direct engagement
Ongoing
For Compliance and Communication
Banks and 
Financial 
Institutions
No
E-mail, letters, meetings
Ongoing
Financial requirements, Compliance and 
transactions
PRINCIPLE 5: Businesses should respect and promote human rights.
Essential Indicators:
1.	
Employees and workers who have been provided training on human rights issues and policy(ies) of the entity, in the following 
format:
Category
FY 2024-25
FY 2023-24
Total (A)
No. of employees / 
workers covered (B)
% (B/A)
Total (C)
No. of employees / 
workers covered (D)
% (D/C)
Employees
Permanent
349
349
100%
377
377
100%
Other than permanent
0
0
0%
0
0
0 %
Total Employees
349
349
100%
377
377
100%
Workers
Permanent
330
330
100%
312
312
100%
Other than permanent
260
260
100%
236
236
100%
Total Workers
590
590
100%
548
548
100%
STATUTORY 
REPORTS
17
ANNUAL REPORT 2024-25
2.	
Details of minimum wages paid to employees and workers, in the following format:
Category
FY 2024-25
FY 2023-24
Total (A)
Equal to  
Minimum Wage
More than 
Minimum Wage
Total (D)
Equal to  
Minimum Wage
More than 
Minimum Wage
No. (B)
% (B/A)
No. (C)
% (C/A)
No. (E)
% (E/D)
No. (F)
% (F/D)
Employees
Permanent
Male
329
0
0%
329
100%
359
0
0%
359
100%
Female
20
0
0%
20
100%
18
0
0%
18
100%
Other than permanent
Male
0
0
0%
0
0%
0
0
0%
0
0%
Female
0
0
0%
0
0%
0
0
0%
0
0%
Workers
Permanent
Male
330
0
0%
330
100%
312
0
0%
312
100%
Female
0
0
0%
0
0%
0
0
0%
0
0%
Other than permanent
Male
259
0
0%
259
100%
234
0
0%
234
100%
Female
1
0
0%
1
100%
2
0
0%
2
100%
3.	
Details of remuneration / salary / wages, in the following format:
	
a.	
Median remuneration / wages:
Category
Male
Female
Number Median remuneration / salary / 
wages of respective category
Number Median remuneration / salary / 
wages of respective category
Board of Directors (BoD)
5#
17,125,044
1^
190,000
Key Managerial Personnel
5*
17,125,044
0
0
Employees other than BoD and KMP
324
370,411
20
179,954
Workers
330
263,319
0
0
	
# Out of 5 Directors, 3 are executive directors who are paid remuneration, rest are independent directors who only receive sitting fee.
	
^ We have only one female independent director, who is paid sitting fee. Please refer corporate governance report for details
	
* includes MD and WTDs.
	
b.	
Gross wages paid to females as % of total wages paid by the entity, in the following format:
FY 2024-25
FY 2023-24
Gross wages paid to females as % of total wages
1.93%
1.54%
4.	
Do you have a focal point (Individual / Committee) responsible for addressing human rights impacts or issues caused or contributed 
to by the business? (Yes/No)
	
Yes, the focal point is the Team-HR which takes care of human rights issues.
5.	
Describe the internal mechanisms in place to redress grievances related to human rights issues.
	
The Company has established a human rights policy that is communicated to every employee. Employees are encouraged to provide 
their feedback and there are anonymous reporting mechanisms set up for sharing their concerns and grievances. We have developed 
a Human Rights checklist to improve human rights reporting across our units. It was found that, none of the manufacturing units 
considered were found to have any risk for incidents of child labor, forced labor and young workers exposed to hazardous work. All 
hiring is done with supporting documentation and proof of age required.
18
TATVA CHINTAN PHARMA CHEM LIMITED
6.	
Number of complaints on the following made by employees and workers:
Category
FY 2024-25
FY 2023-24
Filed during 
the year
Pending 
resolution at the 
end of the year
Remarks
Filed during 
the year
Pending 
resolution at the 
end of the year
Remarks
Sexual Harassment
0
0
NA
0
0
NA
Discrimination at workplace
0
0
NA
0
0
NA
Child Labour
0
0
NA
0
0
NA
Forced Labour / Involuntary 
Labour
0
0
NA
0
0
NA
Wages
0
0
NA
0
0
NA
Other human rights related 
issues
0
0
NA
0
0
NA
7.	
Complaints filed under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013, in the 
following format:
FY 2024-25
FY 2023-24
Total Complaints reported under the Sexual Harassment on of Women at Workplace 
(Prevention, prohibition and Redressal) Act, 2013 (POSH)
0
 0
Complaints on POSH as a % of female employees / workers
0
0
Complaints on POSH upheld
0
0
8.	
Mechanisms to prevent adverse consequences to the complainant in discrimination and harassment cases.
	
All major labour laws and other policies about workplace ethics are well communicated to employees through Intranet and other 
forms of communication. These include policies such as the whistle blower policy, the sexual harassment policy and strict legal 
compliance observed as laid down by local and national acts and regulations. There is no discrimination in recruitment, development, 
promotion based on gender, age, religion or disability.
9.	
Do human rights requirements form part of your business agreements and contracts? (Yes / No)
	
Yes. Our endeavor is always to insert and include Company’s expectations to promote sustainability, fair competition and respect for 
human rights.
10.	 Assessments for the year:
% of your plants and offices that were assessed  
(by entity or statutory authorities or third parties)
Child Labour
100%. Our Team HR takes a survey by randomly selecting employees 
and contractors for evaluation. An external auditor verifies and 
assesses the processes followed by our HR team. Regulatory inspectors 
also verify the processes being followed in our manufacturing plants.
Forced / Involuntary Labour
Sexual Harassment
Discrimination at Workplace
Wages
Others – please specify
11.	 Provide details of any corrective actions taken or underway to address significant risks / concerns arising from the assessments at 
Question 10 above.
	
Not Applicable
STATUTORY 
REPORTS
19
ANNUAL REPORT 2024-25
PRINCIPLE 6: Businesses should respect and make efforts to protect and restore the environment.
Essential Indicators:
1.	
Details of total energy consumption (in Joules or multiples) and energy intensity, in the following format:
Parameter
FY 2024-25
FY 2023-24
From renewable sources (in Gigajoules)
Total electricity consumption (A)
0
0
Total fuel consumption (B)
0
0
Energy consumption through other sources (C)
0
0
Total energy consumed from renewable sources (A+B+C) (in Gigajoules)
0
0
From non-renewable sources (in Gigajoules)
Total electricity consumption (D)
74388.49
75072.25
Total fuel consumption (E)
128142.01
101576.85
Energy consumption through other sources (F)*
3936.10
2548.42
Total energy consumed from non-renewable sources (D+E+F) (in Gigajoules)
206466.60
179197.52
Total energy consumed (A+B+C+D+E+F) (in Gigajoules)
206466.60
179197.52
Energy intensity per rupee of turnover 
(Total energy consumed (in Gigajoules) / Revenue from operations)
0.0000563
0.0000473
Energy intensity per rupee of turnover adjusted for Purchasing Power Parity (PPP)
(Total energy consumed (in Gigajoules) / Revenue from operations adjusted for PPP)**
0.0011641
0.0009668
Energy intensity in terms of physical output
(Total energy consumed (in Gigajoules) / per tonne of production)
28.32
25.11
Energy intensity (optional) – the relevant metric may be selected by the entity
-
-
 
* Other sources include petrol and fuel consumption for Company owned vehicles and DG set used during power cutoff or maintenance.
 
** The intensity adjusted for PPP has been restated following the guidelines set forth in SEBI's circular dated 20 December 2024, which outlines Industry 
Standards Forum guidance for BRSR Core. The PPP factor has been sourced from IMF database. The restatement has led to a decrease of 10.70% in the 
reported value for the intensity adjusted for PPP for FY 2023-24.
	
Note: Indicate if any independent assessment / evaluation / assurance has been carried out by an external agency? (Y/N) If yes, name 
of the external agency.
	
No, the company did not carry out independent assessment by an external agency..
2.	
Does the entity have any sites / facilities identified as designated consumers (DCs) under the Performance, Achieve and Trade (PAT) 
Scheme of the Government of India? (Y/N) If yes, disclose whether targets set under the PAT scheme have been achieved. In case 
targets have not been achieved, provide the remedial action taken, if any.
	
Not applicable
3.	
Provide details of the following disclosures related to water, in the following format:
Parameter
FY 2024-25
FY 2023-24
Water withdrawal by source (in kiloliters)
(i) Surface water
0
0
(ii) Groundwater
0
0
(iii) Third party water
83554
85717
(iv) Seawater / desalinated water
0
0
(v) Others
0
0
Total volume of water withdrawal (in kiloliters) (i + ii + iii + iv + v)
83554
85717
Total volume of water consumption (in kiloliters)
78908
81196
Water intensity per rupee of turnover (Total water consumption / Revenue from 
operations)
0.0000215
0.0000214
Water intensity per rupee of turnover adjusted for Purchasing Power Parity (PPP)
(Total water consumption / Revenue from operations adjusted for PPP)*
0.0004449
0.0004381
Water intensity in terms of physical output
(Total water consumption (in kiloliters) / per tonne of production)
10.82
11.38
Water intensity (optional) – the relevant metric may be selected by the entity
-
-
 
* The intensity adjusted for PPP has been restated following the guidelines set forth in SEBI's circular dated 20 December 2024, which outlines Industry 
Standards Forum guidance for BRSR Core. The PPP factor has been sourced from IMF database. The restatement has led to a decrease of 10.70% in the 
reported value for the intensity adjusted for PPP for FY 2023-24.
20
TATVA CHINTAN PHARMA CHEM LIMITED
	
Note: Indicate if any independent assessment / evaluation / assurance has been carried out by an external agency? (Y/N) If yes, name 
of the external agency.
	
No, the company did not carry out independent assessment by an external agency.
4.	
Provide the following details related to water discharged:
Parameter
FY 2024-25
FY 2023-24
Water discharge by destination and level of treatment (in kiloliters)
(i)	
To Surface water
0
0
	 -	
No treatment
0
0
	 -	
With treatment – please specify level of treatment
0
0
(ii) 	 To Groundwater
0
0
	 -	
No treatment
0
0
	 -	
With treatment – please specify level of treatment
0
0
(iii) 	 To Seawater
0
0
	 -	
No treatment
0
0
	 -	
With treatment – please specify level of treatment
0
0
(iv) 	 Sent to third-parties
0
0
	 -	
No treatment
0
0
	 -	
With treatment – Tertiary treatment
4646
4521
(v) 	 Others
0
0
	 -	
No treatment
0
0
	 -	
With treatment – please specify level of treatment
0
0
Total water discharged (in kiloliters)
4646
4521
	
Note: Indicate if any independent assessment / evaluation /assurance has been carried out by an external agency? (Y/N) If yes, name 
of the external agency.
	
No, the company did not carry out independent assessment by an external agency.
5.	
Has the entity implemented a mechanism for Zero Liquid Discharge? If yes, provide details of its coverage and implementation.
	
Yes, the Company’s Ankleshwar unit is a zero liquid effluent discharge facility. It recovers and reuses all the wastewater generated 
through the use of effluent treatment plant (ETP), single-effect evaporators and reverse osmosis. The Company focuses on water 
conservation through optimal use, wastewater treatment and reuse.
6.	
Please provide details of air emissions (other than GHG emissions) by the entity, in the following format:
Parameter
Please specify unit
FY 2024-25
FY 2023-24
NOx
Kg/Year
92
676
SOx
Kg/Year
249
1829
Particulate matter (PM)
Kg/Year
6
31
Persistent organic pollutants (POP)
Kg/Year
0
0
Volatile organic compounds (VOC)
Kg/Year
0
0
Hazardous air pollutants (HAP)
Kg/Year
0
0
Others– please specify
Kg/Year
0
0
	
Note: Indicate if any independent assessment / evaluation / assurance has been carried out by an external agency? (Y/N) If yes, name 
of the external agency.
	
No, the company did not carry out independent assessment by an external agency.
STATUTORY 
REPORTS
21
ANNUAL REPORT 2024-25
7.	
Provide details of greenhouse gas emissions (Scope 1 and Scope 2 emissions) & its intensity, in the following format:
Parameter
Unit
FY 2024-25
FY 2023-24
Total Scope 1 emissions
(Break-up of the GHG into CO2, CH4, N2O, HFCs, PFCs, SF6, NF3, if 
available)*
t CO2 eq.
7,663.18
6,969.06
Total Scope 2 emissions (Break-up of the GHG into CO2, CH4, N2O, 
HFCs, PFCs, SF6, NF3, if available)*
t CO2 eq.
15,022.34
15,160.42
Total Scope 1 and Scope 2 emission intensity per rupee of turnover
(Total Scope 1 and Scope 2 GHG emissions / Revenue from 
operations)**
t CO2 eq./ `
0.00000619
0.00000584
Total Scope 1 and Scope 2 emission intensity per rupee of turnover 
adjusted for Purchasing Power Parity (PPP)
(Total Scope 1 and Scope 2 GHG emissions / Revenue from operations
adjusted for PPP)***
t CO2 eq./ `
0.00012791
0.00011939
Total Scope 1 and Scope 2 emission intensity in terms of physical 
output****
t CO2 eq. 
per tonne of 
production
3.11
3.10
Total Scope 1 and Scope 2 emission intensity (optional) – the relevant 
metric may be selected by the entity
 
*  We have enhanced our approach and methodology to adopt a more accurate method of calculating emissions, while reporting scope 1 and scope 
2 emissions in FY 2024-25. Accordingly, the values for FY 2023-24 have been restated to enable comparability of information with FY 2024-25. The 
restatement has led to an increase of 291.04% and decrease of 10.25% in Scope 1 and Scope 2 emissions, respectively.
 
**  We have enhanced our approach and methodology to adopt a more accurate method of calculating emissions, while reporting scope 1 and scope 
2 emissions in FY 2024-25. Accordingly, the values for FY 2023-24 have been restated to enable comparability of information with FY 2024-25. The 
restatement has led to an increase of 18.46% in the intensity per rupee of turnover for FY 2023-24.
 
*** The intensity adjusted for PPP has been restated following the guidelines set forth in SEBI's circular dated 20 December 2024, which outlines 
Industry Standards Forum guidance for BRSR Core. The PPP factor has been sourced from IMF database. The restatement has led to an increase of 
5.81% in the reported value for the intensity adjusted for PPP for FY 2023-24.
 
**** We have enhanced our approach and methodology to adopt a more accurate method of calculating emissions, while reporting scope 1 and scope 
2 emissions in FY 2024-25. Accordingly, the values for FY 2023-24 have been restated to enable comparability of information with FY 2024-25. The 
restatement has led to an increase of 18.32% in the intensity in terms of physical output for FY 2023-24.
	
Note: Indicate if any independent assessment / evaluation / assurance has been carried out by an external agency? (Y/N) If yes, name 
of the external agency.
	
No, the company did not carry out independent assessment by an external agency.
8.	
Does the entity have any project related to reducing Green House Gas emission? If yes, then provide details.
	
Yes, adoption of low emissions fuels is critical in our carbon reduction plan. The Company has switched from high to low emission 
fuels, with our facilities transitioning from LDO to Natural Gas. The Company plans to use renewable energy sources, such as solar / 
wind. In addition to above, the Company has implemented energy efficiency measures across our operations to reduce our energy 
consumption and lower our carbon emissions. 
	
In FY 2024-25, the Company has identified several areas where the Company could improve energy efficiency, including upgrading our 
equipment, optimising our manufacturing processes, and improving insulation. 
	
Energy conservation themes and GHG reduction projects have resulted in improved energy efficiency. Project description: (a) For 
lowcarbon energy consumption project initiative includes LED lamps replacing conventional lights, Installed Pressure Powered 
Pumping Packaged Unit (Ppppu) to reduce power consumption, Replacement of pumps for energy savings, Installed VFD in brine 
plants machines to reduce power consumption and (b) For energy efficiency in production processes project initiative includes 
Internal consumption of byproducts, steam elimination in the last stage of the new dryer and waste heat recovery.
22
TATVA CHINTAN PHARMA CHEM LIMITED
9.	
Provide details related to waste management by the entity, in the following format:
Parameter
FY 2024-25
FY 2023-24
Total Waste generated (in metric tons)
Plastic waste (A)
57.53
37.33
E-waste (B)
0.89
4.73
Bio-medical waste (C)
0.0002
0.0007
Construction and demolition waste (D)
0
0
Battery waste (E)
0
0
Radioactive waste (F)
0
0
Other Hazardous waste. Please specify, if any. (G)
3974.48
5307.75
Other Non-hazardous waste generated (H). Please specify, if any. (Break-up by 
composition i.e. by materials relevant to the sector)
0
0
Total (A+B + C + D + E + F + G + H)
4032.90
5349.81
 Waste intensity per rupee of turnover
 (Total waste generated / Revenue from operations)
0.0000011
0.0000014
Waste intensity per rupee of turnover adjusted for Purchasing Power Parity (PPP)
(Total waste generated / Revenue from operations adjusted for PPP)*
0.0000227
0.0000289
Waste intensity in terms of physical output
(Total waste generated (in metric tons) / per tonne of production)
0.55
0.75
Waste intensity (optional) – the relevant metric may be selected by the entity
NA
NA
For each category of waste generated, total waste recovered through recycling, re-using or other recovery operations (in metric tons)
Category of waste
(i) Recycled
1036.87
2252.51
(ii) Re-used
1533.44
1849.04
(iii) Other recovery operations
0
0
Total
2570.31
4101.55
For each category of waste generated, total waste disposed by nature of disposal method (in metric tonnes)
Category of waste
(i) Incineration
331.84
47.44
(ii) Landfilling
2663.31
1220.95
(iii) Other disposal operations
0
0
Total
2995.15
1268.39
 
* The intensity adjusted for PPP has been restated following the guidelines set forth in SEBI's circular dated 20 December 2024, which outlines Industry 
Standards Forum guidance for BRSR Core. The PPP factor has been sourced from IMF database. The restatement has led to an decrease of 10.53% in 
the reported value for the intensity adjusted for PPP for FY 2023-24.
	
Note: Indicate if any independent assessment / evaluation / assurance has been carried out by an external agency? (Y/N) If yes, name 
of the external agency.
	
No, the company did not carry out independent assessment by an external agency.
10.	 Briefly describe the waste management practices adopted in your establishments. Describe the strategy adopted by your company 
to reduce usage of hazardous and toxic chemicals in your products and processes and the practices adopted to manage such 
wastes.
	
All the waste is handled as required by Consent to Operate / Hazardous Waste authorization of the individual sites. The Company 
has obtained Gujarat Pollution Control Board (“GPCB”) consent to operate the plant in safe manner and all the wastes are collected, 
stored, reused and disposed of in a safe manner as per consent (CC & A) by GPCB. 
	
The Company adopts the strategy of Reduce, Reuse, Recycle, Recovery and Disposal methodology by optimizing and modifying the 
process from time to time. Continuous improvements in manufacturing process and technology is the key to reduce the generation 
of hazardous waste at our site. 
	
Plastic waste generated (during packaging and production) and E-Waste is sent to GPCB approved vendor for recycling and safe 
disposal. 
STATUTORY 
REPORTS
23
ANNUAL REPORT 2024-25
	
Hazardous waste is collected, stored and sent to GPCB approved vendor to dispose of safely. The Company has agreement with all 
these agencies for hazardous waste disposal. Substitution with less hazardous chemicals also contribute positively. High calorific value 
waste is sent to cement kilns for use as co-fuel.
11.	 If the entity has operations / offices in / around ecologically sensitive areas (such as national parks, wildlife sanctuaries, biosphere 
reserves, wetlands, biodiversity hotspots, forests, coastal regulation zones etc.) where environmental approvals / clearances are 
required, please specify details in the following format:
Sr. 
No.
Location of 
operations / offices
Type of 
operations
Whether the conditions of environmental approval / clearance are being complied 
with? (Y/N) If no, the reasons thereof and corrective action taken, if any.
NA
NA
NA
12.	 Details of environmental impact assessments of projects undertaken by the entity based on applicable laws, in the current financial 
year:
Name and brief 
details of project
EIA Notification 
No.
Date
Whether conducted by 
independent external 
agency (Yes/No)
Results communicated 
in public domain (Yes/ 
No)
Relevant Web 
link
NA
NA
NA
NA
NA
NA
13.	 Is the entity compliant with the applicable environmental law / regulations / guidelines in India; such as the Water (Prevention and 
Control of Pollution) Act, Air (Prevention and Control of Pollution) Act, Environment protection act and rules thereunder (Y/N). If 
not, provide details of all such non-compliances, in the following format:
Sr. 
No.
Specify the law / regulation 
/ guidelines which was not 
complied 
Provide details of 
the non- compliance
Any fines / penalties / action taken by 
regulatory agencies such as Pollution 
Control Board or by courts
Corrective action 
taken, if any
NA
NA
NA
NA
NA
PRINCIPLE 7: Businesses, when engaging in influencing public and regulatory policy, should do so in a manner that is
responsible and transparent.
Essential Indicators:
1.	
a.	
Number of affiliations with trade and industry chambers / associations.
	
	
6 (Six)
	
b.	
List the top 10 trade and industry chambers / associations (determined based on the total members of such body) the entity 
is a member of / affiliated to.
Sr. 
No
Name of the trade and industry chambers / associations
Reach of trade and industry chambers / 
Associations (State/National)
1
Ankleshwar Industries Association
State
2
Bharuch District Management Association
State
3
Vadodara Chamber of Commerce and Industry
State
4
Dahej Industries Association
State
5
Export Promotion Council for EOUS & SEZ Units
National
6
Basic Chemicals Cosmetics & Dyes Export Promotion Council (CHEMEXCIL)
National
2.	
Provide details of corrective action taken or underway on any issues related to anti-competitive conduct by the entity, based on 
adverse orders from regulatory authorities.
Name of authority
Brief of the case
Corrective action taken
Not Applicable
PRINCIPLE 8: Businesses should promote inclusive growth and equitable development.
Essential Indicators:
1.	
Details of Social Impact Assessments (SIA) of projects undertaken by the entity based on applicable laws, in the current 
financial year
Name and brief 
details of project
SIA Notification 
No.
Date of 
notification
Whether conducted by 
independent external agency 
(Yes/No)
Results communicated 
in public domain (Yes/ 
No)
Relevant 
Web link
Not Applicable
24
TATVA CHINTAN PHARMA CHEM LIMITED
2.	
Provide information on project(s) for which ongoing Rehabilitation and Resettlement (R&R) is being undertaken by your entity, in 
the following format:
S.
No
Name of Project for 
which R&R is ongoing
State
District
No. of Project Affected 
Families (PAFs)
% of PAFs covered 
by R&R
Amounts paid to PAFs in 
the FY (In `)
Not Applicable
3.	
Describe the mechanisms to receive and redress grievances of the community
	
The Company works closely with the community in the identified areas for carrying out the Corporate Social Responsibility initiatives. 
Within the area of work, the employees of the Company work with the communities to understand the impact of the projects on the 
intended beneficiaries. These interactions provide the people with ample opportunities to gauge and address community concerns. 
Based on these interactions, we have not received any specific grievances from the community at present.
4.	
Percentage of input material (inputs to total inputs by value) sourced from suppliers.
FY 2024-25
FY 2023-24
Directly sourced from MSMEs/ small producers
37.38%
26.90%
Directly from within India
69.14%
59.06%
5.	
Job creation in smaller towns – Disclose wages paid to persons employed (including employees or workers employed on a 
permanent or non-permanent / on contract basis) in the following locations, as % of total wage cost
Location
FY 2024-25
FY 2023-24
Rural
30.59%
24.59%
Semi-urban
4.23%
4.57%
Urban
39.56%
40.48%
Metropolitan
25.62%
30.37%
	
(Place to be categorised as per RBI Classification System - rural/semi-urban/urban/Metropolitan)
PRINCIPLE 9: Businesses should engage with and provide value to their consumers in a responsible manner.
Essential Indicators:
1.	
Describe the mechanisms in place to receive and respond to consumer complaints and feedback.
	
The Company has a well-established consumer complaint redressal system for its customers. Complaints are resolved within the time- 
bound period, depending on the nature of the complaint, and escalated to next level in case the same remains unresolved within the 
stipulated time frame.
	
To ensure customer complaints are redressed promptly and effectively, the Company has put in place a customer complaint SOP and has 
a Quality Assurance (“QA”) team that is responsible for handling customer complaints. Complaint records are maintained by HOD-QA. 
The Complete record contains complaint details, an investigation report, a response to the complainant, and the closure of complaint 
handling process. Appropriate Corrective and Preventive actions are being taken. The procedure after receipt of complain is as below:
Schematic flow chart of handling market complaints
Marketing Department forward the complaints to Quality Assurance Department
QA Manager categorizes the complaint Critical / Major / Minor & assign complaint number
 
QA Manager in coordination with the concerned department arrange investigation
 
Record the details of Investigation in the Investigation Report, Draft the reply is prepared and forwarded to QA for approval.
QA Manager shall forward the approval reply to Head Marketing with a copy to Director within 30 working days
Marketing Department shall reply to the customer with a copy to QA & Director
STATUTORY 
REPORTS
25
ANNUAL REPORT 2024-25
Grievance Redressal Mechanism: Key Highlights
i.	
Easy upload and creation of complaints
	
On receipt of communication, written or verbal, directly from any customers, regarding the Quality, defect in the purity, efficacy, 
safety, labeling defects, physical appearance, shortages, complaint related to adverse reaction or any other such complaints are 
considered as Market Complaints. All such complaints should be addressed and forwarded to the QA department through marketing 
department. Upon receipt of the market complaint, designee QA shall make entry of complaint details in Customer complaint register 
(Format no. SOP/QA/004/F1) and assign customer complaint number.
ii.	
Verification of customer credentials, customer information security
	
Customer communicates complaint/s to Marketing Department and response to customer complaints are communicated to customer 
by Marketing Department.
iii.	
Complaint ID acknowledgement mail and advisory to customers
	
The Marketing department acknowledges the customer within 24 hours of receiving the complaint. Upon receipt of the market 
complaint, the designated QA shall enter the complaint details in the Customer complaint register and assign a customer complaint 
number. A brief investigation report shall be prepared, along with corrective and preventive action. Such an investigation report shall 
be forwarded to customer within 30 working days, and an appropriate CAPA shall be implemented.
iv.	
Assignment of Complaints
	
In-charge QA shall review the nature of complaint and shall define type of complaint i.e. Major or Minor. As per the customer 
complaint SOP, the Company has to ensure that complaints are resolved effectively and promptly. A category of complaint is assigned 
and responded to by the quality assurance department.
v.	
Monitoring and Analysing Complaints
	
The quality assurance department carries out root cause analysis on a regular basis by applying problem-solving techniques. A brief 
investigation report shall be prepared, along with corrective and preventive action. It should be signed by concerned departmental 
personnel and approved by Manager QA. Such an investigation report shall be forwarded to customer within 30 working days, and 
appropriate CAPA shall be implemented. If response regarding the complaint from the customer is satisfactory. Designee QA shall 
make entry for complaint closing in Market complaint register. This visibility ensures that complaints are resolved.
2.	
Turnover of products and / services as a percentage of turnover from all products / service that carry information about:
As a percentage to total turnover
Environmental and social parameters relevant to the product
100%
Safe and responsible usage
100%
Recycling and / or safe disposal
100%
3.	
Number of consumer complaints in respect of the following:
Nature of Complaint
FY 2024-25
FY 2023-24
Received during 
the year
Pending 
resolution at end 
of year
Remarks
Received during 
the year
Pending resolution 
at end of year
Remarks
Data privacy
0
0
NA
0
0
NA
Advertising
0
0
NA
0
0
NA
Cyber-security
0
0
NA
0
0
NA
Delivery of essential 
services
0
0
NA
0
0
NA
Restrictive Trade Practices
0
0
NA
0
0
NA
Unfair Trade Practices
0
0
NA
0
0
NA
Other
0
0
NA
0
0
NA
26
TATVA CHINTAN PHARMA CHEM LIMITED
4.	
Details of instances of product recalls on account of safety issues:
Number
Reasons for recall
Voluntary recalls
0
Not applicable
Forced recalls
0
Not applicable
5.	
Does the entity have a framework / policy on cyber security and risks related to data privacy? (Yes/No) If available, provide a web-
link of the policy.
Policy available (Yes/No)
Yes
Web Link
https://www.tatvachintan.com/webfiles/CorporateGovernance/PDF/tatva-chintan-data-privacy-
cyber-security-policy.pdf
6.	
Provide details of any corrective actions taken or underway on issues relating to advertising, and delivery of essential services; 
cyber security and data privacy of customers; re-occurrence of instances of product recalls; penalty / action taken by regulatory 
authorities on safety of products / services.
	
Not Applicable, as there were no issues or concerns related to advertising, delivery of essential services, cyber security, penalties or 
actions initiated by regulatory authorities for safety of Company’s products.
7.	
Provide the following information relating to data breaches:
	
a.	
Number of instances of data breaches
	
	
Nil
	
b.	
Percentage of data breaches involving personally identifiable information of customers
	
	
Not applicable
	
c.	
Impact, if any, of data breaches
	
	
Not applicable
STATUTORY 
REPORTS
27
ANNUAL REPORT 2024-25
